Contineum Therapeutics, Inc. (CTNM) stock
CTNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.55−0.12 (-1.24%)
Close on Nov 17, 2026Market cap $359.28MP/E –Yield –
Contineum Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Contineum Therapeutics's price to book ratio was 1.5× on Nov 11, 2026, against 1.6× a year earlier. Over the last 2 years it ranged from 0.4× to 2.3×, with a median of 1.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.5× | −0.2 |
| 2025 | Dec 31, 2025 | 1.7× | +0.7 |
| 2024 | Dec 31, 2024 | 1.0× | – |
See a number that looks wrong?